CTCL
Clinical trials for CTCL explained in plain language.
Never miss a new study
Get alerted when new CTCL trials appear
Sign up with your email to follow new studies for CTCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial offers hope for Tough-to-Treat skin cancer patients
Disease control Recruiting nowThis study is testing an experimental drug called PTX-100 for adults with cutaneous T-cell lymphoma that has returned or hasn't responded to at least two previous treatments. Participants receive PTX-100 through IV infusions in repeating cycles for up to 18 months. The main goal …
Matched conditions: CTCL
Phase: PHASE2 • Sponsor: Prescient Therapeutics, Ltd. • Aim: Disease control
Last updated Apr 01, 2026 22:56 UTC
-
Light therapy gel targets skin cancer in final test phase
Disease control Recruiting nowThis study is testing whether a gel called HyBryte, which is activated by a special light, can help treat early-stage cutaneous T-cell lymphoma (CTCL), a type of skin cancer. About 80 participants will apply the gel or a placebo to their skin patches twice a week for 18 weeks, fo…
Matched conditions: CTCL
Phase: PHASE3 • Sponsor: Soligenix • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New dressing aims to cut steroid use for cancer Patients' painful skin
Symptom relief Recruiting nowThis study is testing if a flexible wound dressing called StrataCTX can help reduce the need for steroid creams in people with painful skin reactions. These reactions can be caused by skin lymphoma (CTCL) or by chemotherapy/immunotherapy treatments for other cancers. The main goa…
Matched conditions: CTCL
Phase: NA • Sponsor: Columbia University • Aim: Symptom relief
Last updated Mar 30, 2026 14:31 UTC